Centessa Pharmaceuticals plc
NASDAQ:CNTA · NASDAQ Global Select
-$0.07 today
Vol 5.55M · Avg 2.63M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+207.85%
Period High
$40.02
Period Low
$13.00
Latest
$40.02
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Apogee Therapeutics, Inc.
NASDAQ:APGE
$5.54B
CG Oncology, Inc. Common stock
NASDAQ:CGON
$5.49B
Legend Biotech Corporation
NASDAQ:LEGN
$5.36B
Celcuity Inc.
NASDAQ:CELC
$4.27B
Xenon Pharmaceuticals Inc.
NASDAQ:XENE
$4.27B
Dyne Therapeutics, Inc.
NASDAQ:DYN
$3.28B
Soleno Therapeutics, Inc.
SLNO
$2.76B
Ultragenyx Pharmaceutical Inc.
NASDAQ:RARE
$2.76B
Zai Lab Limited
NASDAQ:ZLAB
$2.12B
Ascentage Pharma Group International
NASDAQ:AAPG
$402.07M
What is the latest CNTA filing?
The latest filing shown is 8-K dated Jun 12, 2026.
How many recent filings does CNTA have?
Intrinsic Alpha currently shows 20 recent filings for CNTA.
Explore More
Continue the stock analysis
Jump to another research area for this company.